MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Movement disorder specialists’ determination of eligibility for device aided treatment in advanced Parkinson’s disease: Results from the OBSERVE-PD study

    A. Fasano, K. Seppi, V.SC. Fung, J.C. Parra, L. Bergmann, A. Yegin, K. Sail, Y. Jalundhwala, K. Onuk (Toronto, ON, Canada)

    Objective: To characterize the clinical and non-clinical features of ‘advanced’ PD patients considered to be eligible or ineligible for device-aided treatment (DAT) options by movement…
  • 2017 International Congress

    The occurrence of dopamine-responsive and dopamine-resistant resting tremor in Parkinson’s disease

    H. Zach, M. Dirkx, D. Roth, j. Pasman, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: To investigate dopamine-responsiveness of resting tremor in Parkinson’s disease Background: Unlike the core Parkinson motor symptom, bradykinesia, resting tremor has a variable response to…
  • 2017 International Congress

    A novel paradigm of variable frequency deep brain stimulation to improve freezing of gait in Parkinson’s disease

    F. Jia, A. Wagle Shukla, w. Hu, L. Almeida, M. Okun, L. Li (Beijing, China)

    Objective: To determine the effects of a novel deep brain stimulation (DBS) paradigm of combining high and low frequency stimulation in varying patterns (VFS) for…
  • 2017 International Congress

    Evolution in Dopamine Transporter (DaT) Scan Utilization Patterns and its Effect on Treatment Decisions:  Results of the Next 200 Scans

    X.X. Yu (Cleveland, OH, USA)

    Objective: To describe further changes in DaT scan utilization and its influence on management following our initial experience.   Background: We previously reported our DaT scan…
  • 2017 International Congress

    Metabolic changes following transcranial magnetic resonance-guided focused ultrasound subthalamotomy

    R. Rodriguez-Rojas, R. Martinez-Fernandez, J. Pineda-Pardo, C. Sanchez-Catasus, M. del Alamo, J. Obeso (Mostoles, Spain)

    Objective: As part of a pioneer trial to investigate the use of transcranial magnetic resonance-guided focused ultrasound subthalamotomy (MRgFUS-STN) in Parkinson's disease (PD), this study addresses…
  • 2017 International Congress

    Speech difficulties are linked to striatal dopaminergic deficits and cognitive decline in early de novo patients with Parkinson’s disease

    S. Polychronis, F. Niccolini, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate whether speech difficulties are associated with striatal dopaminergic deficits and whether are linked to progression of symptoms in early de novo patients…
  • 2017 International Congress

    Decreased Fronto-Parietal connection is associated with face pareidolia in Parkinson’s disease.

    Y. Kajiyama, M. Mihara, Y. Mitani, H. Otomune, H. Fujimoto, G. Revankar, K. Konaka, H. Mochizuki (Osaka, Japan)

    Objective: To investigate the neural mechanism of face pareidolia in Parkinson’s disease (PD) patients using resting state functional magnetic resonance imaging (rs-fMRI). Background: Face pareidolia…
  • 2017 International Congress

    Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

    M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

    Objective: Investigating the role of dopaminergic medication on the neural mechanisms underlying lower limb motor automaticity during fMRI in 23 patients with PD that were…
  • 2017 International Congress

    The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the association between phosphodiesterase 4 (PDE4) expression and sleep disturbances in vivo using combined multimodal magnetic resonance imaging (MRI) and…
  • 2017 International Congress

    Clinical utility of visualization of Nigrosome-1 in patients with Parkinson’s disease

    A. Sunny, R. Naduthota, R. Botta, S. Varadharajan, J. Saini, R. Yadav, P. Pal (Bangalore, India)

    Objective: To determine the inter-rater reliability of Nigrosome-1 detection and its relation to asymmetry of clinical symptoms in Parkinson’s disease (PD).  Background: Detection of Nigrosome-1…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley